Dolby Laboratories, Inc. (NYSE:DLB) Shares Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets grew its position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 123.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,041 shares of the electronics maker's stock after buying an additional 16,578 shares during the quarter. BNP Paribas Financial Markets' holdings in Dolby Laboratories were worth $2,346,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in DLB. Fifth Third Bancorp lifted its stake in Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after buying an additional 163 shares in the last quarter. Nisa Investment Advisors LLC increased its position in Dolby Laboratories by 436.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock worth $29,000 after buying an additional 301 shares in the last quarter. Mather Group LLC. raised its holdings in shares of Dolby Laboratories by 36.8% in the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock worth $41,000 after acquiring an additional 142 shares during the last quarter. Headlands Technologies LLC purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at $57,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of Dolby Laboratories during the fourth quarter valued at $71,000. Hedge funds and other institutional investors own 58.56% of the company's stock.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 675 shares of Dolby Laboratories stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $75.04, for a total transaction of $50,652.00. Following the transaction, the senior vice president now directly owns 121,151 shares of the company's stock, valued at $9,091,171.04. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 38.39% of the stock is owned by insiders.

Dolby Laboratories Trading Down 0.4%

Shares of NYSE DLB traded down $0.27 on Thursday, reaching $75.49. 28,163 shares of the company traded hands, compared to its average volume of 449,337. The stock has a market capitalization of $7.25 billion, a PE ratio of 27.76 and a beta of 0.95. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66. The company has a 50 day moving average of $76.30 and a 200 day moving average of $78.55.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 EPS for the quarter, topping the consensus estimate of $1.29 by $0.05. The firm had revenue of $369.56 million during the quarter, compared to analyst estimates of $375.44 million. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. Dolby Laboratories's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.27 earnings per share. As a group, research analysts expect that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 21st. Investors of record on Tuesday, May 13th were given a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 1.75%. The ex-dividend date of this dividend was Tuesday, May 13th. Dolby Laboratories's dividend payout ratio (DPR) is currently 49.81%.

Analyst Ratings Changes

A number of analysts recently commented on the company. StockNews.com downgraded shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st. Tigress Financial began coverage on shares of Dolby Laboratories in a report on Thursday, May 15th. They set a "buy" rating and a $112.00 price target for the company. Barrington Research reissued an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday, May 2nd. Finally, Rosenblatt Securities decreased their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.